Navigation Links
Mouse model provides a new tool for investigators of human developmental disorder
Date:4/20/2009

April 21, 2009, Cambridge, UK Wolf-Hirschhorn Syndrome (WHS) is a human disease caused by spontaneous genetic deletions. Children born with WHS have a characteristic set of facial features, including a wide flat nose bridge, downturned mouth, high forehead, and highly arched eyebrows. Other symptoms associated with this disease include heart defects, seizures, mental retardation, and skeletal abnormalities, and the severity of these symptoms varies between individual WHS patients.

While it was known that WHS is related to a genetic deletion in chromosome 4, the specific gene or genes affected were unknown. Now, a study by scientists at the European Molecular Biology Laboratory demonstrates that a gene called Fgfrl1 (Fibroblast growth factor receptor-like 1) plays a key role in WHS.

This report published in Disease Models & Mechanisms (DMM), dmm.biologists.org describes how they modify the Fgrfrl1 gene so that it loses function, then express the gene in mice. Fgfrl1 in humans is located on the short arm of chromosome 4 and mice born with the modified Fgfrl1 gene have a variety of physical features that are similar to characteristics seen in WHS patients. For example, the mice are born with heart defects due to thickening of the cardiac valves, and they have abnormal facial and skeletal structures compared to normal mice. The mutant mice also have deformities in throat cartilage structures, which may provide insight to the swallowing and speaking difficulties experienced by many WHS patients.

This mouse model of WHS provides a valuable new tool for researchers studying this developmental disorder. It provides a new avenue for molecular research through study of Fgrf1 function, but also allows scientists to understand how structural defects might contribute to WHS symptoms, as is the case in the heart defects and swallowing difficulties.

The report, "Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice" was written by Catarina Catela, Daniel Bilbao-Cortes, Esfir Slonimsky, Paschalis Kratsios, Nadia Rosenthal and Pascal te Welscher of the European Molecular Biology Laboratory in Monterotondo, Italy. The report is published in the May/June issue of Disease Models & Mechanisms (DMM), a research journal published by The Company of Biologists, a non-profit based in Cambridge, UK.


'/>"/>

Contact: Donna Perry
donna@biologists.com
44-012-234-33319
The Company of Biologists
Source:Eurekalert

Related biology news :

1. CSHL team develops mouse models of leukemia that predict response to chemotherapy
2. Brain building: Study shows brain growth tied to cell division in mouse embryos
3. A worm-and-mouse tale: B cells deserve more respect
4. Salk researchers develop novel glioblastoma mouse model
5. Peering inside the skull of a mouse to solve meningitis mystery
6. Multiple sclerosis research charges ahead with new mouse model of disease
7. Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder
8. Anything but modest: The mouse continues to contribute to humankind
9. Let the cat keep chasing the mouse
10. Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research
11. Disabling mouse enzyme increases fertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
Breaking Biology News(10 mins):
(Date:9/14/2017)... (PRWEB) , ... September 14, 2017 , ... AIM Global, ... Medical Tracking Systems Inc. has won the 2017 Case Study Competition for AIDC. ... which provide benefits that decrease risk” and push the adoption of automated data collection ...
(Date:9/13/2017)... (PRWEB) , ... September 13, 2017 , ... ... with the life sciences industry to improve patient outcomes and quality of life ... & impurities, has been named a US expert to the International Standards ...
(Date:9/12/2017)... ... September 12, 2017 , ... PhysIQ, a Chicago-based company that ... patient monitoring and clinical trial support, earned DPharm Idol 2017 honors at the ... , Launched in 2005, PhysIQ leverages artificial intelligence (AI) to empower digital health. ...
(Date:9/12/2017)... , ... September 12, 2017 ... ... http://www.globalspecimensolutions.com ) has announced the release of their latest product LabCODE™, a ... storage requirements. LabCODE™ offers pre-built capabilities for Biobanking, Pharmacokinetics, Pharmacogenetics, Next ...
Breaking Biology Technology: